Related Experiment Video
Updated: Aug 6, 2025

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Characteristics of Decedents With COVID-19-Related Mortality in Kentucky, July 1-August 13, 2021
Alyson M Cavanaugh1,2, Likhita Raparti2, Mishaal Bhurgri2
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Objective:
Although vaccination reduces the risk of severe COVID-19, fatal COVID-19 cases after vaccination can occur. We examined the characteristics of decedents with COVID-19-related mortality to help inform discussions about vaccination, boosters, and mitigation strategies.
Methods:
We examined COVID-19-related deaths in Kentucky resulting from infections occurring from July 1 through August 13, 2021. We used records from case investigations, medical records, the Kentucky Health Information Exchange, and the Kentucky Immunization Registry to determine demographic information, vaccination status, and underlying health conditions, including calculation of the Charlson Comorbidity Index (CCI). We calculated mortality incidence rates by vaccination status by using data for unvaccinated and fully vaccinated populations in Kentucky as of July 1, 2021.
Results:
In total, 777 COVID-19-related deaths occurred in Kentucky during the study period; 592 (76.2%) occurred among unvaccinated people. Compared with unvaccinated decedents, fully vaccinated decedents were older (median age, 77 vs 65 years; P < .001), had higher comorbidity levels (median CCI, 3 vs 1; P < .001), and were more likely to have immunocompromised health status (26.4% vs 16.0%; P = .003). Diabetes, hypertension, heart disease, and chronic lung disease were more common among vaccinated decedents than among unvaccinated decedents. Unvaccinated adults had a significantly higher risk of death than fully vaccinated adults (incidence rate ratio for age 20-49 years: 20.5 [95% CI, 6.5-64.8]; 50-64 years: 14.6 [95% CI, 9.4-22.7]; ≥65 years: 10.2 [95% CI, 8.3-12.4]).
Conclusions:
Immunocompromised health status, older age, and higher comorbidity were prevalent among fully vaccinated decedents, suggesting adults with these characteristics may benefit from additional protection strategies. Further understanding of the protection of additional and booster doses is needed.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Contingency Table
Endocarditis II: Clinical Features of Infective Endocarditis
Microsoft Excel: Finding Central Tendency, Skew, and Kurtosis
Mean: The arithmetic average of all data points. It is calculated by adding all the values together and dividing by the number of values. The mean is sensitive to extreme values (outliers).
Median: The middle value when the data points are arranged in ascending or descending...
Acute Kidney Injury III: Clinical Manifestations

